fromwww.theguardian.com1 month agoIf AstraZeneca goes to the US it will be a major blow for London and LabourPascal Soriot is considering moving AstraZeneca's corporate base to the US, impacting the company's UK presence and raising concerns in the scientific community.
London startupfromwww.independent.co.uk2 months agoVaccine maker's 1bn UK investment to create hundreds of high-skilled jobs'BioNTech's investment will significantly enhance the UK's life sciences sector by creating jobs and fostering research.
London startupfromBusiness Matters4 months agoUK life sciences losing 15bn a year to global rivalsThe UK's life sciences sector is losing £15 billion annually due to reduced investment and exports.